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Trachoma is the leading infectious cause of blindness and is endemic in 52 countries. There is a critical need
to further our understanding of the host response during disease and infection, as millions of individuals are
still at risk of developing blinding sequelae. Infection of the conjunctival epithelial cells by the causative
bacterium, Chlamydia trachomatis, stimulates an acute host response. The main clinical feature is a follicular
conjunctivitis that is incompletely defined at the tissue-specific gene expression and molecular levels. To
explore the features of disease and the response to infection, we measured host gene expression in conjunctival
samples from Gambian children with active trachoma and healthy controls. Genome-wide expression and
transcription network analysis identified signatures characteristic of the expected infiltrating immune cell
populations, such as neutrophils and T/B lymphocytes. The expression signatures were also significantly
enriched for genes in pathways which regulate NK cell activation and cytotoxicity, antigen processing and
presentation, chemokines, cytokines, and cytokine receptors. The data suggest that in addition to polymorph
and adaptive cellular responses, NK cells may contribute to a significant component of the conjunctival
inflammatory response to chlamydial infection.
Chlamydia trachomatis is an obligate intracellular bacterium
that infects millions of people worldwide. Infection of conjunc-
tival epithelial cells causes trachoma, which is the world’s lead-
ing infectious cause of blindness, affecting over 40 million
people in the developing world (50). C. trachomatis is also the
world’s most common bacterial sexually transmitted infection
(STI), with an estimated 92 million new cases of C. trachomatis
urogenital infections occurring annually (74). Asymptomatic
infection is common, and untreated cases are at risk of developing
complications related to fertility and pregnancy (6). A vaccine to
prevent C. trachomatis infection or disease progression would be
of great value, but the development of such a vaccine is handi-
capped by the fact that the immunological correlates of protective
immunity and pathogenesis are not well understood.
The immune and inflammatory responses initiated by C.
trachomatis infection, although important for successful con-
trol and resolution of infection, are thought to be at least partly
responsible for tissue damage and its sequelae (10). Some
progress has been made in dissecting correlates of protective
immunity and immunopathology in humans (14), but reports
are dominated by studies using the mouse as a model system
(reviewed in reference 54). The extrapolation of results ob-
tained from murine experimental models needs cautious inter-
pretation. Several papers have demonstrated the exquisite and
often subtle adaptations of chlamydial parasites to their natu-
ral host tissues and the specificity of the molecular pathways
that control intracellular replication (53, 58, 67).
Ocular C. trachomatis infection is readily accessible to ex-
amination and investigation. As a result, the clinical and epi-
demiological features of trachoma and the phases of disease
are well documented in many populations (49). Trachomatous
inflammation (follicular) (TF) and/or trachomatous inflamma-
tion (intense) (TI) is characterized by C. trachomatis-driven
conjunctival inflammation and is most prevalent during child-
hood (10 years). Conversely, the sequelae of these earlier
stages, i.e., trachomatous conjunctival scarring (TS), trachoma-
tous trichiasis (TT), and corneal opacity (CO), are most prev-
alent in adults (45 years) and require repeated or persistent
episodes of infection and inflammation.
Gene expression profiling studies have used a variety of
array platforms to study the host response to chlamydial infec-
tion (2, 18, 32, 43, 44, 47, 64, 66, 70, 86, 89, 93). With the
exception of two recent studies (43, 64), each has described the
in vitro response in experimentally infected cell lines or cells
isolated from tissue. Numerous genes and pathways have been
implicated as being important in the innate response to infec-
tion. Thus far, there have been no transcriptome-defining stud-
ies of human tissues that are infected or diseased as a result of
natural chlamydial infection. To gain a better understanding of
the immune and inflammatory responses to ocular C. tracho-
matis infection in humans, we collected conjunctival swabs
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from the upper tarsal conjunctiva of Gambian children with
active trachoma and examined their transcriptomes using ge-
nome-wide expression arrays.
The extraction of biological meaning from microarray data is
challenging and complex. This has led to the development of
many new computational tools and methods for their analysis.
We used statistical methods to define differential gene expres-
sion and a graph theoretic method to define networks of co-
expressed transcripts (27). The latter method analyzes the de-
gree of correlation (coexpression) between transcripts (79) and
can help define the transcriptional networks which are charac-
teristic of the cell types present in conjunctival samples.
MATERIALS AND METHODS
Ethical approval. The study was approved by the Gambia Government/Med-
ical Research Council Joint Ethics Committee (reference L2006.47) and by the
Ethics Committee of the London School of Hygiene and Tropical Medicine
(LSHTM). Written informed consent was obtained from all study subjects or
their guardians. Children diagnosed with clinical signs of active trachoma were
treated according to National Eye Care Programme guidelines with topical
tetracycline or a single oral dose of azithromycin (20 mg/kg).
Study subjects. Infants and children from the North Bank, Western, and
Central River regions in the Gambia were screened for clinical signs of trachoma.
Sterile polyester-tipped swab (Hardwood Products, ME) samples were collected
from the upper tarsal conjunctiva from 200 children with clinical signs of inflam-
matory trachoma and from control subjects without clinical signs of active tra-
choma. Clinical diagnosis was made according to the WHO detailed trachoma
grading system (30); each subject was graded based on follicular score (F0 to F3),
papillary score (P0 to P3), and conjunctival scarring score (C0 to C3), with the
presence of clinically active trachoma indicated by a follicular score of 2 or 3
(F2/F3) or a papillary score of 3 (P3). These are equivalent to trachomatous
inflammation (follicular) (TF) and trachomatous inflammation (intense) (TI) of
the WHO simplified trachoma grading system, respectively (81).
Anesthetic eye drops (Minims Proxymetacaine 0.5%; Chauvin Pharmaceuti-
cals, Romford, United Kingdom) were administered prior to swab collection.
Swab collection was performed in a standardized manner (12). Two swabs per
eye were collected; the first swab (swab A) was collected into RNAlater (Am-
bion, Huntingdon, United Kingdom), and the second swab (swab B) was col-
lected in a dry polypropylene tube. Both samples were stored on ice until frozen
(20°C) in the laboratory on the same day. Samples were then shipped on dry ice
to the London School of Hygiene and Tropical Medicine (LSHTM).
Processing of conjunctival swab samples for human gene expression studies.
Total RNA was extracted from swab A samples using the RNeasy micro kit
(Qiagen, Crawley, United Kingdom) according to the manufacturer’s instruc-
tions with modifications previously described (56). Total RNA was immediately
stored at 80°C until processed for gene expression (within 1 month). For each
total RNA sample, a 2-l aliquot was used to estimate the concentration of RNA
using a NanoDrop ND-1000 spectrophotometer (ThermoScientific, Waltham,
MA). RNA quality was assessed with an Agilent 2100 Bioanalyzer (Agilent, Palo
Alto, CA).
Processing of conjunctival swab samples for diagnosis and quantification of C.
trachomatis. DNA was extracted from dry conjunctival swabs (swab B) for diag-
nosis and quantification of C. trachomatis as described by Solomon et al. (72).
The Amplicor CT/NG diagnostic kit (Roche Molecular Systems, Branchburg,
NJ) was used as a qualitative PCR for C. trachomatis. Both Amplicor-positive
and -negative samples were then purified using DNA extraction spin columns
(QIAmp DNA mini kit; Qiagen, Crawley, United Kingdom) and tested by a C.
trachomatis quantitative PCR (qPCR) which amplifies a 123-bp fragment within
constant domain 3 of the C. trachomatis ompA gene using sets of primers which
amplify each of the reference ocular serovars. The samples were then stratified
into high-load infections and low-load infections, defined as 390 and 34
copies of C. trachomatis ompA per swab, respectively (12).
Microarray analysis. Samples for analysis were selected from subjects based
on clinical diagnosis, C. trachomatis infection status (determined by a positive
result in the CT/NG Amplicor diagnostic test), and adequate quantity and quality
of extracted total RNA. A total of 60 samples were selected for microarray
analysis: 20 samples were from subjects with active trachoma (all had F2 with
or without P0) and C. trachomatis infection (group DI), 20 were from subjects
with clinical signs of active trachoma but without detectable C. trachomatis ocular
infection (group D), and 20 were from subjects without clinical signs of active
trachoma in both eyes and absence of C. trachomatis infection (group N).
Total RNA (100 ng) from each subject was subjected to two rounds of in vitro
transcription with biotin-labeled nucleotides (two-cycle cDNA synthesis and
labeling kit; Affymetrix, Santa Clara, CA). A hybridization cocktail was made
according to the Affymetrix protocol using 15 g of biotinylated and fragmented
cRNA and hybridized to Affymetrix Human Genome U133 Plus 2.0 arrays
(GeneChips) for 16 h at 45°C according to the manufacturer’s standard proto-
cols. GeneChips were washed and stained following the standard Affymetrix
protocol and scanned using the Affymetrix confocal laser scanner 3000. These
GeneChips contained 54,675 probe sets representing47,400 human transcripts.
The analyzed data are available at http://www.macrophages.com/index_GE
_microarray.html.
Microarray data processing and statistical analysis. Array data files (.cel)
were run through Bioconductor R (http://www.bioconductor.org/) in order to
perform quality assessment and normalization. The data set was normalized
using the Robust Multichip Average (RMA) algorithm (40). Normalized data
were then subjected to an interquartile range (IQR) filtering, in which array
features with an IQR of 0.5 log2 intensity unit were discarded, removing
outliers and weakly expressed probe sets. Group mean differences in average
expression for each transcript were tested through empirical Bayes moderated t
tests (Bioconductor package limma). The simultaneous testing of a large number
of variables was accounted for by controlling the false-discovery rate (FDR) at
the 1% level (8). Large-scale differential gene expression was estimated in two
ways: first by calculation of B values (log odds of p [transcript is differentially
expressed]/p [transcript is not differentially expressed]), where a B value of 0
indicates that transcripts are more likely than not to be differentially expressed,
and second by fold change gene expression, defined as transcripts with an ad-
justed P value of0.01 and log2 fold change (FC) of0.7 (FC 0.6) and0.7
(FC  1.6) or 1.0 (FC  0.5) and 1.0 (FC  2.0).
Network analysis. A sample-to-sample Pearson correlation matrix of normal-
ized total gene expression was calculated using the cor function within R. A
graph was then generated using the matrix file in BioLayout Express3D (www
.biolayout.org/) (27). An overall gene expression graph was then generated using
the normalized IQR-filtered gene expression data and was then arranged ac-
cording to patient clinical and infection classification (i.e., N, D, and DI). Briefly,
Pearson correlation coefficients (r) were calculated for all pairs of probe sets on
the array, and r values of 0.7 were stored. These were used to construct
networks represented in 3D by BioLayout Express3D in which nodes represent
the probe sets (transcript) and are linked by an edge if the Pearson correlation
r between the probe sets exceeds a cutoff value. After selecting a cutoff r value of
0.85, the graph was then partitioned using the Markov Clustering (MCL)
algorithm (85) at an MCL inflation value of 2.2 (27). The inflation value controls
the granularity of clustering (the higher the value, the more granular the clus-
tering), and this value has been determined empirically as being optimal for most
large expression graphs (27). The partitioned clusters contain transcripts that
exhibit a high degree of coexpression across the samples that are statistically
differentially expressed between subject groupings, as well as those that show no
differential expression between groups (39, 48).
Gene set enrichment analysis. Gene lists consisting of statistical and differen-
tially expressed genes or MCL defined gene transcription clusters from network
analysis were tested for enrichment or overrepresentation of content in biolog-
ical pathways and cell types using the NIH database for annotation, visualization,
and integrated discovery (DAVID) (http://david.abcc.ncifcrf.gov/) (37, 38). De-
fault value settings were used, and fold enrichments with unadjusted P values
(EASE scores) were calculated using a modification of the Fisher’s exact test. To
complement DAVID v6 analysis, two additional enrichment tools were used
Onto-tools Pathway Express (http:vortex.cs.wayne.edu/projects.htm) (42) and
the Molecular Signatures Database (MSigDB) (78) using the C2 “curated gene
sets” and canonical pathways (www.broadinstitute.org/gsea/msigdb). Analogous
to DAVID, these analysis tools calculate a hypergeometric P value that indicates
the likelihood that the content of the gene list is overrepresented (or enriched)
in particular terms, functions, or membership of canonical pathways.
Selection of transcripts for classification of disease and infection. For classi-
fication we selected uniquely expressed transcripts from each of the clinical and
infection groups. For the DI group, 23 transcripts that had the largest changes in
fold change expression were selected. Probe sets that targeted the same tran-
script were not included. This set of probe sets was then used to classify the
samples using a standard k nearest-neighbor (kNN) algorithm and validated
within the data set using leave-one-out cross-validation (LOOCV).
Validation of differentially expressed transcripts. Independent confirmation
of differential gene expression by quantitative reverse transcription-PCR (qRT-
PCR) with the same samples was not possible, due to the limited amount of RNA
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obtained in each sample. The data obtained from 60 samples tested on U133 plus
2.0 arrays were compared with data from an independent set of samples from the
same population in which gene expression was measured using Affymetrix HG-
focused target arrays. The series of HG-focused target arrays consisted of 29
arrays in total. Twenty-five of these were from clinical and infection categories
equivalent to those described for the U133 plus 2.0 arrays. RNA amplification,
labeling, and hybridization were carried out with the same methods described
above. The samples were from 8 participants with no clinical signs of active
trachoma (F0 and P2) and absence of C. trachomatis infection, 10 participants
with active disease (F2) but negative for C. trachomatis infection, and 7 par-
ticipants with active trachoma (F2) with a positive test for C. trachomatis
infection. The remaining four arrays in this series were from participants without
the clinical signs of active trachoma but positive by Amplicor PCR. In addition,
data were available from previous studies of conjunctival gene expression, mea-
sured by qRT-PCR, in populations in areas where trachoma is endemic (24).
Microarray data accession numbers. The raw data obtained for the 60 U133
plus 2.0 arrays were deposited in the NCBI archive (www.ncbi.nlm.nih.gov/geo/)
Gene Expression Omnibus under accession number GSE20436. The raw data for
the 29 HG-focused target arrays were deposited in the Gene Expression Omni-
bus under accession number GSE20430.
RESULTS
C. trachomatis infection. Age and gender distributions were
comparable among the clinical groups (see Table S1 in the
supplemental material). The median age of participants was 6
years (range, 1 to 13 years). The C. trachomatis infection loads
ranged from 19 to 185,270 C. trachomatis ompA copies per
swab. A positive result by Amplicor and increasing conjunctival
load were significantly associated with clinical severity (F
score) (see Table S2 in the supplemental material) (36). High-
load infection was detected in the majority (11/20) of Ampli-
cor-positive participants. The high-load infections accounted
for all but one of the participants with the highest clinical
severity scores. The quantified load in a minority of Amplicor-
positive participants amplified with a reverse primer which
binds genovar B ompA strain types more efficiently than geno-
var A ompA strain types, and these samples are indicated in
Table S1 in the supplemental material (35).
Clustering of study subjects by global conjunctival gene
expression correlation. Quality control of Affymetrix gene ex-
pression data demonstrated that all data were of a consistent
and high quality. The pairwise Pearson correlation coefficient
of global gene expression was used as the distance metric to
construct a matrix from which the individual samples were
hierarchically clustered using a agglomerative clustering algo-
rithm with complete linkage (Fig. 1a). This clustered the sam-
ples into three main branches. Branch 1 (n 26) contains 95%
of the samples from healthy subjects. Of the remaining samples
in this branch, seven had F scores of 2 and a single sample
had evidence of current intermediate-level infection (134 cop-
ies per swab). One participant also had papillary inflammation
(P2). Branch 2 (n 21) contained the single remaining sample
from a subject with a normal conjunctiva. The remaining 20
samples in this branch were collected from subjects with fol-
licular scores of F2 or papillary scores of P3. Fifteen of
these had no or low-level infection (34). Three samples had
intermediate infection loads, and three had high-load infection
(390 copies per swab). Branch 3 (n  13) contained subjects
with the highest infection loads and clinical grades of disease
(F2 or P2). Eighty-four percent of the participants in
branch three were infected, of whom over half (8/13) had high
(390) infection loads. It is not surprising that the overall
range of correlation between these 60 arrays is narrow (be-
tween 0.9 and 1.0), since the overwhelming majority of genes
do not have altered expression between the clinical and infec-
tion states. Pairwise correlation of global expression stratified
by disease severity or infection load was also explored using
BioLayout Express3D (Fig. 1b), and this confirms that the ex-
pression profiles cluster with clinical and infection phenotypes.
Identification of genes differentially expressed during infec-
tion and disease. Large numbers of transcripts were both up-
and downregulated when healthy and disease groups (with and
without current infection) were compared (Table 1). There
was a 2-fold change in the level of expression in 2,316 tran-
scripts in samples derived from individuals with clinical disease
and infection compared to healthy, infection-free individuals.
However, the presence of disease signs alone induced differ-
ential expression of only 421 transcripts compared to healthy
individuals. Among individuals with disease, the additional
presence of C. trachomatis infection induced differential ex-
pression in 341 transcripts (the full gene list can be found in
Table S3 in the supplemental material).
The major and fine biologies of the differentially regulated
genes were explored using the DAVID v6 database. Each of
the differentially regulated gene lists showed significant gene
enrichment for numerous annotation terms. The top-ranked
gene ontology (GO) terms were typical of immune system
activation, epithelial cell integrity, apoptosis, cell death, leuko-
cyte migration, and interleukin receptor activity (Table 2). In
particular, genes involved in pathways that control cell adhe-
sion, chemokine signaling, antigen (Ag) processing and pre-
sentation, and regulation of the actin cytoskeleton were
strongly represented.
Identification of differentially regulated transcripts for clas-
sification. The probe sets that were differentially expressed
(2-fold change and adjusted P value of 0.01) were sepa-
rated in a Venn diagram that identified probe sets with signif-
icant differential expression unique to each comparison (Fig.
2). The samples from participants who were diseased and in-
fected contained the vast majority of the transcripts with great-
est changes in expression compared to normal conjunctiva.
Other comparisons had relatively few unique transcripts (N
versus D  23 and D versus DI  23). The principal newly
identified GO terms uncovered indicated enrichment of genes
characteristic of neutrophils and mast cell biology during dis-
ease and infection episodes. The use of a set of 63 probe sets
defined as uniquely expressed in each comparison classified the
samples with 75% accuracy across the three clinical groups
(Fig. 3; see Table S4 in the supplemental material). The true
class and the kNN class are shown in Fig. 3 with a heat map of
expression intensity. Samples are ordered by clinical category
and within-group similarity of expression.
Comparison of Affymetrix array gene expression results
with previous independent studies of gene expression in tra-
choma. We compared the data obtained from this set of sam-
ples and arrays with data from previous studies in which par-
ticipants were of equivalent age range and in which the
diagnosis of current infection was made using the same PCR
test (CT/NG Amplicor). Data were available from an indepen-
dent set of samples from the same population in which gene
expression was measured using Affymetrix HG-focused target
arrays. The comparative results are shown in Tables S5a to S5d
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in the supplemental material. Overall there was strong corre-
lation of fold change for all probe sets common to each array
platform. This became very strong when genes with high levels
of fold change were considered. Some probe sets, such as
CXCL13 and S100A7, had high levels of fold change on one
array platform (U133 plus 2.0) and low levels on the second
platform; however, in each case the fold changes were statis-
tically significant. Previous studies using qRT-PCR to estimate
gene expression with conjunctival samples from children with
active trachoma were also correlated with gene expression by
microarray analysis. The highest degree of correlation was
always obtained from the comparison of group N with group
DI in all studies and platforms.
Transcription networks in the conjunctiva. The undirected
network graph based on a Pearson correlation (r) threshold of
0.85 contained 9,993 nodes (probe sets) representing approx-
imately 8,359 genes connected by 245,457 edges. MCL cluster-
ing partitioned the network into 577 clusters of coexpressed
genes. These clusters ranged in size from 1,148 to 4 transcripts
and accounted for 7,719 (77.3%) of the probe sets in the
original network. Probe sets that formed clusters containing
4 members that were part of the network were not assigned
FIG. 1. (a) Similarity of global gene expression clusters samples into three distinct groups. The axes of the matrix are clustered with a simple
tree, which represents sample distance based on the global similarity of gene expression (sample-to-sample Pearson correlation coefficient). The
trachoma clinical grading and infection scores are shown on the right hand side (F, follicular score; P, papillary hypertrophy score; Amplicor, C.
trachomatis PCR positive or negative; C. trachomatis load, qPCR estimate of the number of C. trachomatis ompA copies per swab). The
genome-wide expression profiles of conjunctival tissue from 60 Gambian subjects resident in communities where trachoma is endemic were used
to construct the 60-by-60 matrix. The expression across all 54,675 probe sets on the HG-U133 plus 2.0 GeneChip were used. Three main branches
(1, 2, and 3) cluster the samples into groups based on the biological signature of their overall gene expression profile. Samples defined by a branch
share the greatest similarity with each other. Overall, the separation achieved by the unsupervised clustering of the samples has a true class accuracy
value of 70% and implies that the three groups have a different expression signature. (b) Sample-to-sample correlation network represented in
BioLayout Express3D. A matrix file was generated by comparing the overall expression pattern of all samples (as in panel a) and used to generate
a graph of the data. In this context, nodes represent samples and the edges correlation values between them greater than the selected threshold
(r  0.95). The thicker/redder is the edge, the higher is the sample-to-sample correlation that it represents. Panel A, nodes colored light blue
represent samples derived from healthy participants showing no clinical signs of disease or infection, those colored green represent participants
who had clinical signs of disease but no detectable infection, and those colored red represent participants with clinical signs of disease and C.
trachomatis infection. Panel B, nodes colored gray represent samples derived from participants showing no detectable levels of infection, those in
yellow represent those with C. trachomatis loads of 34 copies per swab, those in green represent C. trachomatis loads of 34 to 389, and those in
red represent loads f 390. Panel C, nodes colored gray represent participants with an F score of 0, those colored blue represent participants with
an F score of 2, and those colored maroon represent participants with an F score of 3. Panel D, nodes colored gray represent participants with
a P score of 0, those colored green represent participants with a P score of 1, those colored blue represent participants with a P score of 2, and
those colored maroon represent participants with a P score of 3.
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a cluster number (no class) and accounted for remaining 2,274
probe sets. Clusters established by MCL were assigned a num-
ber according to the number of probe sets they contained;
MCL1 contained the largest number of probe sets (1,148),
while MCL577 contained four probe sets. Each MCL cluster
was assigned an arbitrary color, and the graph (Fig. 4) was
explored for evidence of functional enrichment of gene clusters
and the relationships between genes and clusters (the full list
of transcripts and cluster assignment is available in Table S6 in
the supplemental material). The graph (Fig. 4) shows the in-
terrelationships and overlapping nature of the main large clus-
ters and the discrete separation of other, smaller clusters. A
number of small but interesting clusters confirm the power of
this approach in identifying and grouping coexpressed genes.
For example, MCL33 and -47 are derived from the probes for
the Affymetrix labeling controls (24 probe sets) and the Af-
fymetrix hybridization controls (19 probe sets), respectively.
MCL37 was made up entirely of transcripts derived from the Y
chromosome, which are expressed only in males. The clusters
MCL12, -13, and -22 were all highly enriched with ribosomal
genes.
The partitioned graph of 577 clusters contained three basic
classes of clusters: genes in which expression was unchanged
across all samples, genes whose expression was increased dur-
ing infection and disease, and genes whose expression was
downregulated during infection and disease. The gene/tran-
script content of each cluster and their associated biological
function are provided in Table S6 in the supplemental mate-
rial. The major and fine biologies of the members of each of
the major transcriptional networks with the numbers of differ-
entially regulated genes are summarized in Tables 3 and 4.
Individuals with active disease and infection exhibit al-
tered expression profiles that are enriched with genes in-
dicative of T cell and NK cell activation. The largest cluster
of upregulated genes was MCL2. Manual inspection of this
cluster and DAVID v6 analysis indicated that this cluster
contained genes typical of NK cells, T cells, and macrophages.
Of particular interest was the upregulation of genes associated
with NK and T cell ligand-receptor complexes (PTPN6, NCR3-
CD3Z, CD244-CD48, NKG2D-DAP10, CD86, CD8, CD28,
CD2, CD45, CD4, CD3D, and CD3E), intracellular signal-
transduction mediators of the T-cell receptor (TCR) cascade,
and nuclear proteins mediating expression of genes controlling
the functions of Th1 lymphocytes (TXK and NFATC) and
activation of major histocompatibility complex (MHC) class
II transcription (RFX5). This cluster also contains members
of the killer cell immunoglobulin-like receptors (KIRs),
some of which regulate the cytotoxic function of NK cells via
MHC class I ligands. These include inhibitors of NK-medi-
FIG. 1—Continued.
TABLE 1. Summary of the total number of transcripts with altered expression associated with
each comparison of clinical and ocular infection status
Comparison
No. of transcripts
B  0 Fold change n AdjustedP  0.01
Expected false
positives
Direction of gene
expression change
N vs DI 18,792 0.6 and 1.6 4,993 4,845 48 Up 2,024
Down 2,821
0.5 and 2.0 2,365 2,316 23 Up 1,104
Down 1,212
N vs D 8,325 0.6 and 1.6 1,457 1,172 12 Up 491
Down 681
0.5 and 2.0 468 421 4 Up 195
Down 226
D vs DI 4,100 0.6 and 1.6 1,418 894 9 Up 445
Down 459
0.5 and 2.0 482 341 3 Up 151
Down 190
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ated activation (KIR2DL5A), cell triggering complexes as-
sociated with NK mobilization and cytotoxicity (FCER1G/
KIR2DL4, KIR3DL2, KIR2DS2, and KIR3DL1), and genes of
the C-type lectin superfamily involved in the regulation of NK
cell function and costimulation of CD8 T cells (KLRD1and
KLRK1). The activating natural killer (NK) cell receptor
NCR3, perforin (PRF1), and granzyme B (GZMB) are also
represented in the cluster. Other prominently expressed genes
present in this cluster encode secreted proteins regulating NK
and Th1 cell recruitment and activation at sites of inflamma-
tion. These include the adhesion molecules ADAM19, ITGB7,
ICAM3, and VCAM1; chemokines and receptors (CCR5,
CCL5, and CXCR6); and cytokines and receptors (IFNG,
IL2RG, interleukin-16 [IL-16], IL12RB1, IL12RB2, IL-32,
LTA, IL10RA, and CSF1R). Evident within MCL2 are genes
controlling homeostatic regulation of inflammatory mediators
(e.g., anaphylatoxins [C3AR1]) via increased expression of
PDE4B and PDE3B, GPR132, PTGDR, prostaglandins
PLA2G2D and, the tumor necrosis factor (TNF) receptor su-
perfamily (TNFRSF25 and TNFSF8).
Using network analysis and gene set enrichment, we consis-
tently identified overrepresentation of transcripts with a role in
NK cell biology. Therefore, the fold change expression values
for each probe set from MCL2 were imported into the KEGG
database defined pathway map for NK cell-mediated cytotox-
icity (Fig. 5). This provides a visual representation of the ca-
nonical pathway for the activation of NK cells. The greatest
changes in expression intensity are evident in the subjects with
infection and disease signs. Since analysis based purely on
differential expression (2-fold changes) (Tables 1 and 2) also
identified enrichment of genes in this pathway, we submitted
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FIG. 2. Identification of genes with high-degree changes in expres-
sion unique to each clinical and infection category, based on 2-fold
changes. The biology of each of the gene lists was investigated by
testing for enrichment or membership of pathways using DAVID v6,
and the major GO terms are listed. The main features reflect those
identified based only on high-degree differential expression (Table 2).
Influx and activation of cells important in innate immune responses,
such as neutrophils and mast cells, are prominent during disease and
infection. Humoral and cytokine/chemokine responses typical of adap-
tive responses appear as expected and are shared between groups.
Genes unique to each category were used to generate a small list of
genes that could be used to classify participants based on expression
profiles and to identify either biomarkers or important expression
pathways.
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the list of differentially regulated genes to an expression per-
turbation analysis tool (Onto-tools Pathway Express). The re-
sults indicated that the largest predicted effects based on en-
richment and fold changes were on the same MCL2-enriched
pathways and provided further supporting evidence for stimu-
lation of NK cell-mediated cytotoxicity.
Transcripts typical of neutrophils and interferon signaling
form overlapping clusters. MCL3 consists of 271 transcripts,
and the average profile of expression is similar to that of
MCL2; this can be visualized in Fig. 4, which shows the prox-
imity of these two clusters in the coexpression network. The
cluster is dominated by genes typical of leukocyte biology and
innate host defense (cytokines, chemokines, and Toll-like re-
ceptors [TLRs]). Several members of the Toll-like receptor
family (TLR1, TLR2, TLR4, and TLR8) were present in this
cluster. The expression signature of cytokine receptors in-
volved in cell-cell signaling is characteristic of the innate im-
mune response that induces transcription of inflammation-
related genes (IL8RA, IL8RB, CSF3R, CSF2RB, IL1B, IL1A,
IL1R2, and IL6R) as well as those involved in humoral and
adaptive immunity. MCL3 also contains receptors for granu-
locyte-macrophage colony-stimulating factors (CSF3R and
CSF2RB) and mediators of neutrophil migration to sites of
inflammation (CXCL5 and MMP25). Consequently, genes in-
volved in many of the processes of phagocytosis, cell-mediated
cytotoxicity, chemotaxis, or cellular activation of NK cells,
monocytes, and neutrophils are represented (CR1, C5AR1,
and CFP), including those genes modulating iron metabolism
(SLC11A1) and intracellular superoxide production (FPR1,
NCF2, and NCF4). MCL3 also has upregulation of genes that
FIG. 3. Classification of individuals based on differentially expressed transcripts. Transformed expression levels are indicated by the color scale,
with red representing relatively high expression and green indicating relatively low expression compared to the median expression for each gene
across all participants. Hierarchical clustering of 63 gene classifiers obtained from selecting genes with 2-fold changes in expression which are
unique to each participant category is shown. Selection of a small subset from the largest group of uniquely expressed genes (1,644 in the disease
and infection class) was based on the fold change and absence of correlation of expression with the genes identified for the other unique classes
(23 genes in each). Selection of a relatively small list of genes as potential biomarkers is a requirement for the application of computationally
efficient methods. A supervised learning algorithm (kNN) was used to test the capacity of the classifier subset of genes to discriminate three classes
of participants. Leave-one-out cross-validation of the training set with 63 genes classified the samples with 75% accuracy. The predicted class is
indicated by light-color solid rectangles (green for healthy participants, amber/yellow for participants with clinical disease signs only, and red
for participants with disease signs with current ocular C. trachomatis infection). Participants from all categories are misclassified; however,
misclassified participants are those with disease signs only (9/20). Two patients with clinical disease and infection were classified as healthy
uninfected participants, and no healthy participants were classified as diseased and infected.
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balance inflammatory responses, such as SLA, LILRB3,
SOCS3, and protease inhibitors (SERPINA1). Manual anno-
tation and enrichment analysis therefore suggests that this
cluster is comprised of genes expressed predominately in neu-
trophils.
The expression profiles of MCL8 and -10 are highly similar,
are upregulated during disease, and are further upregulated
with high C. trachomatis loads (Fig. 6). These clusters have a
signature of type I and II interferon (IFN)-regulated genes.
These include assembly of MHC class I molecules and the
presentation of endogenous peptides to CD8 T cells (TAP1
and TAP2), induction of apoptosis in infected cells presenting
antigen–MHC-I complexes by cytotoxic T lymphocytes (CTL)
(PRF1, GZMA, and GZMB), and expression of CTL cell
adhesion molecules (ITGAL and CD226). There is a chemo-
kine and cytokine pattern indicative of cell-mediated adaptive
immune responses (IL2RA, IL15RA, JAK2, STAT1, STAT4,
and IL-22) and IFN-inducible genes (IFI1/2/3/5/7, STAT1/2,
and IRF1/7). Other well-established markers of the IFN-	
response, such as GBP1/2/5, were upregulated in this cluster,
as, importantly, was INDOL1. INDOL1 is an IFN-	-induced
enzyme that is structurally and functionally similar to the im-
munomodulatory and antimicrobial indoleamine 2,3-dioxyge-
nase (IDO) (IDO, although not part of the MCL8 coexpres-
sion network, was strongly upregulated in those with disease
and infection). Further evidence of activation of other genes in
known IFN-	-induced anti-C. trachomatis pathways was ATF5
and WARS.
MCL8 was also enriched with genes which regulate or
oppose the activation of Th1 cells and IFN-	-induced genes,
such as SOCS1, TFEC, PTGER2, HAVCR2, and TRAFD1
(FLN29). Negative regulators of CTL and NK cell effector
mechanisms such as the serine protease inhibitor SERPINB9
and cell surface receptors (CTLA4 and KLRD1) were also
induced. Although similar in profile, MCL10 is enriched with
genes associated with type I IFN signaling. These include
FIG. 4. Pairwise gene expression correlation network analysis of microarray data derived from 60 trachoma cases and healthy controls. Each
node (sphere) represents a single probe set, and the edges (fine gray lines) connecting them represent a Pearson correlation (r) of0.85. The color
of the nodes represents their membership in a cluster (MCL). The major clusters described in the text are labeled. The smaller isolated clusters
are distinct from the main component and are shown below the main component. The main component shows the overlapping nature and
interrelationship of the coexpression clusters described in the text.
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interferon-induced genes (IFIH1, IFIT2, IFIT3, IFI15, and
ISG20), the interferon regulatory transcription factor IRF7,
and genes associated with host defense against intracellular
infections (MX1, MX2, OAS1, OAS2, OAS3 OASL, DDX58,
RIG-1, and PML).
MCL7 and -9 were comprised of 219 transcripts that were
strongly upregulated during disease with infection. MCL9 con-
tained genes characteristic of the B cell lineage. Genes coding
for members of the B cell antigen receptor complex (FCRL1,
FCRL2, FCRL4, FCRL5, and FCRLA), immunoglobulins,
and the CD79A/CD79B heterodimer were present in this clus-
ter, as well as the classical B cell marker CD19. Other immu-
noglobulin-related genes included those involved in signal
transduction pathways (BLK, SPIB, BACH2, TECs, and
PTKs) triggered by the B cell antigen receptor (BCR and
BRDG1). On the other hand MCL7 was highly enriched with
immunoglobulin genes predominately expressed in plasma
cells, e.g., IGH@, IGAH1, IGHD, IGHG1, IGHM, IGHV1,
IGKC, IGKL@, and IGJ3.
To illustrate the effect of clinical status on the levels of
expression in healthy, diseased, and diseased and infected in-
dividuals, the geometric mean fluorescence intensities of all
the transcripts which belong to a particular MCL or cluster
were calculated. The raw intensity levels and the differences in
these levels between the clinical groups show the effect of
either disease or disease with infection on the level of expres-
sion (Fig. 6). The largest changes in expression across a cluster
of genes are seen in the diseased-with-infection group. Only
rarely did current infection have little effect on expression
(e.g., MCL5).
Other clusters significant in the biology of trachoma. MCL4
was made up almost entirely of genes encoding proteins in-
volved in the S phase of the cell cycle, which were upregulated
with high infection loads. MCL42 is a cluster of upregulated
transcripts which function in lipid metabolism and/or traffick-
ing (APOE, APOC1, SCARB1, and SLC16A1) and innate
intracellular defense. Genes in MCL29 were upregulated dur-
ing disease and infection and included 24 genes coding for
extracellular matrix proteins of connective tissue collagens
(COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, COL5A2,
COL6A2, and COL6A3) and extracellular matrix (ECM) gly-
coproteins (TNC and ASPN). MCL133 was composed of nine
transcripts covering eight genes that are characteristic of con-
junctival goblet cells, such as the trefoil factors (TFF1 and
TFF3) and mucins (MUC5AC and CAPN8). All the genes in
this cluster were downregulated in disease and infection.
Downregulated clusters. Genes that were downregulated in
disease and infection clustered together in the network
(MCL1). MCL1 is the largest single cluster in the network and
was enriched for transcripts in the Wnt signaling pathway.
Other clusters in this downregulated category include MCL11,
-16, -19, -21, -23, and -24.
DISCUSSION
In trachoma, unresolved or repeated ocular C. trachomatis
infection and inflammation causes a progressive fibrotic re-
sponse that can ultimately result in blindness. The conjunctival
scarring observed is more common in those with a severe
inflammatory response to infection. This study describes tis-T
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sue-specific transcriptional networks associated with the re-
sponse to ocular C. trachomatis infection and inflammation.
Previous data suggest that in communities with endemic tra-
choma, individuals who are at different positions in the disease
and infection cycle can be distinguished based on their host
response profile (11, 24, 25). We now show that global tran-
scription profiles can also cluster individuals into the same
types of disease and infection categories. Furthermore, a re-
FIG. 5. Gene expression within cluster MCL2 is enriched in genes affecting NK cell-mediated cytotoxicity. Fold change in gene expression from
MCL2 is shown on the KEGG pathway map (modified from map04650, natural killer cell-mediated cytotoxicity, at the Kyoto Encyclopedia of
Genes and Genomes [KEGG] website http://www.genome.jp/kegg/kegg1.html, with permission). KIR2DL, phosphatidylinositol 3-kinase (PI3K),
and phospholipase C	 (PLC	) depicted in this pathway are represented by multiple gene transcripts in MCL2; in these cases genes are colored
according to the transcript with the largest fold change in expression within a multigene or transcript family (KIR2DL4, PI3KCD, and PLCG2).
Participants with disease and infection had the greatest changes in gene expression (shown on the map by increasing intensities of red). Onto-tools
Pathway Express expression perturbation analysis based only on differentially regulated genes (0.5 and 2.0 at an adjusted P value of 0.01)
comparing healthy subjects with diseased and infected subjects also identifies NK cell-mediated cytotoxicity as substantially affected. An overlap-
ping effect on antigen processing and presentation related primarily to NK cell activity was also observed. The impact factor is the estimated effect
on each pathway as a result of changes in transcript expression in addition to enrichment.
VOL. 78, 2010 C. TRACHOMATIS CONJUNCTIVAL TRANSCRIPTOME ANALYSIS 4905
4906 NATIVIDAD ET AL. INFECT. IMMUN.
duced subset of genes that were statistically differentially reg-
ulated was also able to separate individuals with increased
accuracy into the same categories. This suggests that discrete
expression patterns are associated with these different biolog-
ical states and illustrates the potential to identify an expression
signature for those at most risk of severe inflammation and the
likely development of scarring sequelae.
An initial wave of polymorphonuclear leukocyte influx is a
well-recognized feature of ocular and genital chlamydial infec-
tion that is documented in animal models and in human infec-
tion (69, 92). The prominent neutrophil gene signature iden-
tified in the conjunctiva (MCL3) supports this observation and
suggests that the network and enrichment analyses are robust.
Indeed, signatures typical of granulopoeisis and neutrophil
activation have frequently been identified using genome ex-
pression profiling in response to other classes of infection (9,
30, 63). In some of these infections, in which the focus of
research has been adaptive “protective” T cells, transcriptome
signatures have identified previously hidden type I interferon
signaling pathways present in neutrophils and have suggested
that they are crucial in the control of infection (9). In some
chlamydial infections, depletion of neutrophils delayed the
clearance of infection and increased chlamydial shedding in
the murine genital tract (5). Neutrophils were found to be a
requirement for the recruitment of T cells, particularly CD8
T cells, to the site of infection (19), and in the lung, an in-
creased influx of neutrophils was associated with a greater
chlamydial burden of infection in a susceptible mouse strain
relative to a resistant strain (41). The influx of neutrophils in
the conjunctiva could be attributed to chemokines such as IL-8
and CXCL1, -2, -5, and -6, all of which were upregulated.
Extensive work on the mechanism of neutrophil influx into the
cornea following infection with Onchocerca volvulus has dem-
onstrated the dependence of this influx on multiple factors
originating from cells that are resident in and infiltrate the
tissue (28, 46). The resulting neutrophil influx and activation
was then responsible for keratitis and corneal haze (29). It
therefore seems likely that the control of neutrophil recruit-
ment and activation either by adaptive CD4 Th cells (e.g.,
Th17 cells) or by chemokines secreted by infected epithelial
cells will be crucial, and this requires further investigation.
We found strong induction of gene expression for IFN-	
(MCL2) and IDO in active trachoma and C. trachomatis in-
fection. The production of IFN-	 has a pivotal role in chla-
mydial disease via control of pathogen growth and replication
(68). IFN-	-induced IDO can inhibit proliferation of C. tra-
chomatis in vivo through consumption of the essential amino
acid Trp (65, 80). Previously we have also shown upregulation
of IDO expression in the conjunctiva of subjects with increas-
ing loads of ocular C. trachomatis infection. IDO also has
recognized immunoregulatory properties in both human and
murine cells (61). Therefore, IDO could control the balance
between T cell subset differentiation and local DC priming,
suggesting that C. trachomatis might exploit IDO expression to
induce immunoregulation (5). The identification of inflamma-
tory cells (neutrophils: MCL3) and the upregulation of IFN-	
with T cell receptor signaling pathways (MCL2) together pro-
vide evidence that the arrays reveal elements of the expected
and previously known cellular and gene expression patterns
observed in C. trachomatis disease and infection. We suggest
that this expected result supports the novel observation that
transcripts associated with NK cells and NK cell cytotoxicity,
which are found in MCL2, are over represented and suggests
an important contribution of NK cells in the response to C.
trachomatis infection and disease.
There are a limited number of studies in which NK cells
have been reported to have a demonstrable impact on chla-
mydial disease or infection (33, 34), yet depletion of NK cells
exacerbated the course of disease and infection in mice (83).
Using different gene enrichment approaches, we consistently
found evidence for the contribution of NK cell activation and
cytotoxicity in the conjunctiva of participants with trachoma. In
addition to cytotoxic effects, NK cells could also be a major
source of crucial cytokines such as IFN-	 and IL-22. Thus,
while NK cells may not be essential for the resolution of in-
fection, they may be critical in the inflammatory process and in
the bridge between the adaptive and innate responses. Work
with murine models suggests that adaptive CD4 Th1 cells
which produce IFN-	 are required for the resolution of pri-
mary infections and that in secondary responses other immune
cells can contribute but are not an absolute requirement (87,
90, 91). NK cells can polarize the CD4 T cell response via
dendritic cells (DC), which results in an amplification of IFN-	
production by T cells. NK cells can be helped to produce IFN-	
by other innate cells, such as neutrophils, or by chemokines
derived from infected epithelial cells, such as IL-12 and IL-18.
It is also well recognized that T cell-derived IL-2 can activate
NK cells, and recent evidence suggests that Ag-specific IL-2
from effector memory T cells can in effect immediately “recall”
NK cells which degranulate and secrete IFN-	 (35, 36). Thus,
in the presence of IL-2, IL-12, and IL-18, the local inflamma-
tory responses are directed toward strong type I and IFN-	
responses (1, 26, 73). Therefore, the strong expression signa-
ture of NK cells observed in these conjunctival samples, which
reflects those seen after several natural ocular challenge infec-
tions or episodes of disease, could be explained by the boosting
effect of antigen-specific effector memory T cells. We suggest
that this interaction warrants further in vitro study and inves-
tigation.
The regulation of NK cell activity is complex; epistatic ef-
fects between HLA ligands and KIRs control the activity of NK
cells. The level of diversity in the KIR gene system reflects its
coevolution with MHC class I (71), which encodes the ligands
of some KIRs (15–17, 31). This diversity is generated by hap-
lotypic, allelic (84, 88), and transcriptional (3) variation that
results in a unique KIR expression repertoire. The unusual
FIG. 6. Mean expression levels of all the transcripts in a coexpression cluster for each array are summarized as a single point for each array.
Differences in the expression level for each transcript cluster between each clinical and infection category was then tested by analysis of variance.
Where differences between the groups are significant, they are indicated with the appropriate P value, and this indicates where the changes of
expression are attributable.
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nature of KIR polymorphism and expression can confound the
interpretation of microarray expression studies with respect to
individual KIR alleles or genes. Nevertheless, KIR2DL4,
which is found on all NK cells, can be regarded as a KIR
“framework” locus present (with only rare exceptions) in all
KIR haplotypes (62). Since we find this marker and several
other markers of NK cells to be highly expressed in the con-
junctiva, we suggest that their activity in inflammatory tra-
choma is significant.
The majority of cells from conjunctival swabs are epithelial
cells, and it is well established that infected host epithelial cells
are the source of many of the initiating factors that drive
inflammation (20, 21). This led Stephens to suggest an alter-
native paradigm for the pathogenesis of chlamydial diseases
(75). We found strong induction of many chemokines, pattern
recognition genes (TLRs and NOD [inflammasome] [NOD2,
NLRP3, and NLRP7]), and mediators of inflammation (IL1B).
Clustering of coexpressed genes and annotation of the gene
content of the clusters suggests that infiltrating cells, largely
neutrophils, are a major cellular source of many of these fac-
tors. The largest fold changes in expression were seen for
CXCL5 (epithelial cell-derived neutrophil-activating protein
[ENA-78]), -11, and -13. Strong induction of Cxcl13 has been
described in the development of murine salpingitis, and this
has been suggested as the primary chemokine required for the
development of organized lymphoid tissue in the genital tract
(43). Fractalkine (CX3CL1), a -chemokine expressed by ep-
ithelial cells, DC, and some T cells, was upregulated, and its
expression in response to chlamydial infection has not been
described before. Induction of CXCR3, -4, and -6 was also
observed and is consistent with the recruitment of T cells, NK
cells, monocytes, macrophages, and neutrophils (7, 47, 66).
The increased expression of CXCR6 in chlamydial infection
has not been previously identified. Its cellular distribution
overlaps with that of CCR6, but it is also found on neutrophils
and NKT cells.
Of note among the chemokines and receptors expressed by
the cells entering the conjunctiva were CCL18 and -19. CCL18
is selectively chemotactic for T lymphocytes and has been
shown to be important in pulmonary fibrosis and inflammation
(59, 60). CCL18 can be produced by macrophages, alterna-
tively activated macrophages, dendritic cells (DC-CK1), and in
some circumstances neutrophils (4). The receptor for CCL18
remains to be identified, but it is expressed on T cells that
infiltrate epithelial surfaces. CCL19 is known to mediate the
entry of naive lymphocytes into secondary lymphoid tissue and,
similar to CXCL13, is important in the organization of lym-
phoid tissue. Uniquely, we identify CCR10 and the orphan
receptor CCRL2 as upregulated in active trachoma. CCRL2
has the unusual property of focusing responses, enhancing
chemotaxis of leukocytes by binding and presenting nonche-
mokine chemoattractants to cells with the appropriate chemo-
kine-like receptors. The roles of many CC and CXC ligands
and receptors in chlamydial diseases have been investigated,
mostly on a candidate gene basis or by a selective targeted
approach (7, 64). Our results are consistent for the most part
with the majority of these studies (51, 52). Differences between
our results and those for other tissues likely reflect tissue com-
partmentalization or the differing repertoire of chemokines
shared between Homo sapiens and Mus musculus.
The control of innate responses appears at the center of
several networks, and expression of cytokines such as IL-12
and IL-23 is at the fulcrum of protective acquired immune
responses. Recent work with mice, which differ in susceptibility
to chlamydial pulmonary infection, has shown that the IL-12/
IL-23 balance is altered in DC isolated from susceptible
BALB/c strains. The excessive IL-23 production observed was
suggested to favor the later development of Th17 cells, which
were associated with a larger burden of infection in the lungs
(41). In our study, the expression pattern of IL23A in the
conjunctiva is contained in a transcription network that is char-
acteristic of human epidermal keratinocytes (MCL6). IL-23
promotes inflammatory responses that include upregulation of
MMP9 (45), polymorphism of which is associated with scarring
trachoma. The overall effect of this polymorphism is complex,
since several genes involved in the immune (IFNG and IL-10)
and inflammatory (IL-8 and CSF2) responses alter its protec-
tive or risk-associated effects (55, 57). Although IL-23 is not
involved in Th17 differentiation, it is thought to play an im-
portant role in maintaining Th17 effector function (76, 77) and
therefore in local tissue inflammation. IL-22 expressed by Th17
or Th22 (22, 82) or NK (13) cells was upregulated in active
disease with C. trachomatis infection, whereas its decoy recep-
tor IL22RA2 was upregulated during active disease episodes
free of infection. IL-22 allows cross talk between the immune
system and epithelial cells, and it has been suggested to have
an important role both in host defense and in the pathogenesis
of inflammatory skin diseases such as psoriasis. Th22 cells,
which are a CD4 subset that home to the skin and are im-
portant in the repair of the epithelial barrier (23), therefore
would appear to be important in C. trachomatis infection and
immunity. However, the means to identify a clear and separate
CD4 T helper subtype signature within the background of the
transcriptome expression profiles are not yet available.
Interpretation of expression studies of disease versus control
tissue is often confounded by the very dramatic differences in
the cell populations present. An immune response is orches-
trated by the activity of numerous leukocyte populations, with
each cell expressing genes specific to that population, and in
principle the level of these genes in each sample contributes to
the overall transcriptional signature. Identification of clusters
of coexpressed transcripts that are indicative of these cell types
offers the opportunity to attribute some of the differences in
expression to the cellular content of the tissue. Furthermore,
unlike experimental models of infection where genetically
homogeneous animals or cell lines are challenged with equiv-
alent levels of infectious organisms of the same strain, natu-
rally observed infection in the human population results in
considerable variation, and this must be taken into account as
we interpret the data.
Several observations suggest that transcription network-
based analysis provides a powerful approach and an added
advantage that allows the identification of genes expressed by
particular cell types or those under the influence of the same
transcriptional activators. Combining this with pairwise differ-
ential gene expression, we show that the major networks of
coexpressed and highly regulated genes in the conjunctiva of
participants with active trachoma and C. trachomatis infection
are dominated by genes involved in innate immune responses
and IFN-	-mediated signaling. We have demonstrated the
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prominence of innate responses (NK cells and neutrophils),
underpinned by the balance of IL-12/IL-23 and expression
characteristic of several CD4 helper phenotypes (Th1,Th17,
and Th22 cells).
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